Hospira clinical trials

Acquired by Pfizer, Sep 3, 2015 · source ↗

The registry lists 28 studies whose lead sponsor is Hospira. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 28, 2024.

• 28studies on the registry
• 0open to participants now

Studies

Recruiting first, then most recently updated. Showing 28 of 28. All Pfizer studies →

• Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and OncologyCompletedNCT02140736

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational AgeCompletedNCT01508455Phase 2/3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics SubjectsCompletedNCT00652028Phase 2

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart SurgeryWithdrawnNCT00464763Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to VenoferCompletedNCT00719459Phase 1

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type SedationCompletedNCT01519167Phase 4

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy VolunteersCompletedNCT00745186Phase 1

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With CancerCompletedNCT01268163Phase 1

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative PatientsCompletedNCT00318955Phase 4

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance TreatmentCompletedNCT01170078Phase 1

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy VolunteersCompletedNCT00938678Phase 1

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and OncologyCompletedNCT01626547

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Study Evaluating Safety and Efficacy of Dexmedetomidine (DEX) in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit (PICU) SubjectsCompletedNCT00875550Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational AgeCompletedNCT01159262Phase 2/3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic AgentsCompletedNCT01574235

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and HaematologyCompletedNCT02158169

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without IntubationCompletedNCT01438931Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair SurgeryTerminatedNCT00460473Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy SubjectsCompletedNCT01812538Phase 1

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic IntubationCompletedNCT00383890Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Nivestim™ in Treatment of Malignant DiseasesCompletedNCT01627990

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 MonthsCompletedNCT01378988Phase 2

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) PatientsCompletedNCT01169571

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)CompletedNCT00398827Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous SedationCompletedNCT00216190Phase 4

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU SubjectsCompletedNCT00526760Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic SurgeryCompletedNCT00709436Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer

• Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer PatientsTerminatedNCT00492388Phase 3

  Sponsor listed in the registry: Hospira, now a wholly owned subsidiary of Pfizer · First submitted before Hospira became part of Pfizer